Insight Molecular Diagnostics Inc. IMDX
3.92
(0.03)
(0.76%)
as of 25 Sep
- Market cap
- $129.3M
- P/E
- 0.0×
Follow IMDX
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
(23,500.97%) | 229.65% | 20,228.75% | 488.68% | |
| (106.02%) | (165.10%) | (94.93%) | (123.46%) | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
(338.53%) | (519.57%) | (174.46%) | (303.54%) | |
Average Days of Receivables |
21.39 | 101.53 | 29.40 | 41.96 | |
Free Cash Flow per Share |
(0.75) | (0.83) | (0.80) | (0.84) | |
Free Cash Flow |
(23.91) | (25.37) | (27.47) | (31.00) | |
Capital Expenditures |
(1.92) | (3.18) | (3.49) | (3.92) | |
Piotroski F-Score |
4.00 | 4.00 | 2.00 | 1.00 | |
| Other line items | |||||
Cash ROIC |
(215.06%) | 127.04% | (131.50%) | 1,425.91% | |
Accounts Receivable Turnover |
18.85 | 2.96 | 1.05 | 4.74 | |
Accounts Payable Turnover |
2.08 | 0.84 | 0.49 | 0.55 | |
Inventory Turnover |
5.70 | 4.11 | 2.29 | 1.92 | |
Average Days of Payables |
192.24 | 528.49 | 613.40 | 791.33 | |
Days of Inventory on Hand |
85.74 | 92.65 | 145.09 | 87.55 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
280.05% | 392.11% | 919.91% | 1,146.47% | |
Selling, General and Administrative Expense of Revenue |
366.20% | 418.64% | 926.01% | 1,121.56% | |
Share Based Compensation of Revenue |
45.37% | 54.72% | 121.14% | 150.78% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.36 | 0.44 | 0.50 | 0.55 | |
Depreciation/Fixed assets |
0.53 | 0.34 | 0.26 | 0.41 | |
Capex/Depreciation |
(0.87) | (1.45) | (1.49) | (1.60) | |
Revenue per Share |
0.14 | 0.13 | 0.06 | 0.05 | |
Operating CF per Share |
(0.69) | (0.73) | (0.69) | (0.74) | |
Capex per Share |
(0.06) | (0.10) | (0.10) | (0.11) | |
Capex to Sales |
0.44 | 0.79 | 1.79 | 2.35 | |
Net Profit Margin |
(1,374.72%) | (1,238.52%) | (2,454.64%) | (2,955.63%) |
Columns are period end dates